US Patent 11401348 Heterodimeric Fc variants
Patent 11401348 was granted and assigned to Xencor on August, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 2 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114013480
Date of Patent
August 2, 2022
0Patent Application Number
165399860
Date Filed
August 13, 2019
0Patent Citations
Patent Primary Examiner
Edits on 28 Mar, 2023
Golden AI
Infobox
Patent Citations
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
114013480
Date of Patent
August 2, 2022
0Patent Application Number
165399860
Date Filed
August 13, 2019
0Patent Citations
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 3 Aug, 2022
Golden AI
Edits made to:
Infobox (+10 properties)
Article (+239 characters)
US Patent 11401348 Heterodimeric Fc variants
Article
Immunoglobulin compositions that simultaneously co-engage antigens, where one of the antigens is bound bivalently and the other antigen is bound monovalently. The novel immunoglobulins described preferably utilize heterodimeric Fc regions.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11401348
Date of patent
August 2, 2022
Patent application number
16539986
Date Filed
August 13, 2019
Patent citations
Patent primary examiner
Find more entities like US Patent 11401348 Heterodimeric Fc variants
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
